SG Americas Securities LLC Makes New $20.78 Million Investment in Ryan Specialty Holdings Inc. $RYAN

SG Americas Securities LLC acquired a new stake in Ryan Specialty Holdings Inc. (NYSE:RYAN) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 402,402 shares of the company’s stock, valued at approximately $20,776,000.

Other institutional investors also recently bought and sold shares of the company. Westview Management dba Westview Investment Advisors purchased a new stake in Ryan Specialty in the 4th quarter valued at approximately $2,082,000. JPMorgan Chase & Co. increased its position in Ryan Specialty by 149.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 421,330 shares of the company’s stock worth $23,746,000 after purchasing an additional 252,582 shares during the period. Beck Mack & Oliver LLC purchased a new position in shares of Ryan Specialty during the 3rd quarter worth approximately $2,818,000. Geneva Capital Management LLC lifted its holdings in shares of Ryan Specialty by 11.2% in the 3rd quarter. Geneva Capital Management LLC now owns 535,742 shares of the company’s stock valued at $30,194,000 after buying an additional 53,810 shares during the period. Finally, TD Asset Management Inc lifted its holdings in shares of Ryan Specialty by 2,181.8% in the 3rd quarter. TD Asset Management Inc now owns 205,133 shares of the company’s stock valued at $11,561,000 after buying an additional 196,143 shares during the period. 84.82% of the stock is owned by institutional investors and hedge funds.

Ryan Specialty Stock Performance

Shares of RYAN opened at $31.76 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62. The stock has a market cap of $8.39 billion, a P/E ratio of 75.61, a PEG ratio of 0.86 and a beta of 0.65. The company has a 50-day moving average of $41.31 and a two-hundred day moving average of $49.70. Ryan Specialty Holdings Inc. has a 12-month low of $31.73 and a 12-month high of $77.16.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The company had revenue of $751.21 million during the quarter, compared to analysts’ expectations of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. Ryan Specialty’s quarterly revenue was up 13.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.45 EPS. As a group, research analysts predict that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 24th were paid a dividend of $0.13 per share. The ex-dividend date of this dividend was Tuesday, February 24th. This represents a $0.52 annualized dividend and a dividend yield of 1.6%. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.12. Ryan Specialty’s dividend payout ratio is 123.81%.

Insider Activity

In other news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the stock in a transaction on Monday, February 23rd. The stock was purchased at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the purchase, the director owned 428,295 shares of the company’s stock, valued at approximately $17,114,668.20. The trade was a 6.33% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. 52.21% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have commented on RYAN. Wells Fargo & Company decreased their target price on shares of Ryan Specialty from $63.00 to $56.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Keefe, Bruyette & Woods cut their price target on shares of Ryan Specialty from $65.00 to $55.00 and set an “outperform” rating for the company in a report on Friday, February 13th. Mizuho reduced their price objective on shares of Ryan Specialty from $53.00 to $44.00 and set a “neutral” rating for the company in a research note on Friday, February 27th. BMO Capital Markets downgraded shares of Ryan Specialty from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $66.00 to $43.00 in a report on Wednesday, February 25th. Finally, Zacks Research lowered shares of Ryan Specialty from a “hold” rating to a “strong sell” rating in a research report on Tuesday, February 24th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $54.50.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.